NBTX - NANOBIOTIX Announces Complete Full Cohort Phase 1 Results for JNJ-1900 (NBTXR3) in Inoperable, Recurrent Non-Small Cell Lung Cancer
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.